Dr Joel Castellanos, a respected chronic pain physician at UC San Diego Medical Center, is joining Tryp Therapeutics as clinical advisor. Dr Castellanos will work with Tryp on their psilocybin program to treat neuropathic pain. Dr Castellanos was the lead author on a 2020 review of psychedelics as a proposed mechanism of action against chronic pain ( Castellanos, et al., 2020). News release…


Previous articleStudy: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy
Next articleMindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds